Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
20

Summary

Conditions
Hypertension Pulmonary
Type
Interventional
Phase
Phase 3
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 6 years and 17 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02562235
Collaborators
Merck Sharp & Dohme Corp.
Investigators
Study Director: Bayer Study Director Bayer